Resistance to HER2-targeted anti-cancer drugs is associated with immune evasion in cancer cells and their derived extracellular vesicles

Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer

(2017) Vanesa G. Martinez et al.   INTERNATIONAL JOURNAL OF CANCER

The Biodistribution and Immune Suppressive Effects of Breast Cancer–Derived Exosomes

(2016) Shu Wen Wen et al.   CANCER RESEARCH

Neuromedin U: A Multifunctional Neuropeptide with Pleiotropic Roles

(2015) V. G. Martinez et al.   CLINICAL CHEMISTRY

Expanding on Exosomes and Ectosomes in Cancer

(2015) Lorraine O’Driscoll   NEW ENGLAND JOURNAL OF MEDICINE

Neuromedin U: A Candidate Biomarker and Therapeutic Target to Predict and Overcome Resistance to HER-Tyrosine Kinase Inhibitors

(2014) S. Rani et al.   CANCER RESEARCH

Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation

(2014) Peter Altevogt et al.   SEMINARS IN CANCER BIOLOGY

Plasma Exosomes as Markers of Therapeutic Response in Patients with Acute Myeloid Leukemia

(2014) Chang-Sook Hong et al.   Frontiers in Immunology

Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape?

(2014) Valentin S. Bruttel et al.   Frontiers in Immunology

Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells

(2013) Keith O’Brien et al.   EUROPEAN JOURNAL OF CANCER

EMT and MET in Metastasis: Where Are the Cancer Stem Cells?

(2012) Thomas Brabletz   CANCER CELL

Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro

(2012) Annamaria Marton et al.   IMMUNOLOGY LETTERS

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

(2012) Hasan Korkaya et al.   MOLECULAR CELL

Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes

(2012) Claire Corcoran et al.   PLoS One

p95HER2 and Breast Cancer

(2011) J. Arribas et al.   CANCER RESEARCH

Tumor Metastasis: Molecular Insights and Evolving Paradigms

(2011) Scott Valastyan et al.   CELL

Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells

(2010) Yuelong Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)

(2010) Marta Szajnik et al.   PLoS One

Antitumor Immunity and Cancer Stem Cells

(2009) Tobias Schatton et al.   Annals of the New York Academy of Sciences

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

(2009) JD Mitchell et al.   BRITISH JOURNAL OF PHARMACOLOGY

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes

(2009) E. U. Wieckowski et al.   JOURNAL OF IMMUNOLOGY

Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells

(2008) J. Klibi et al.   BLOOD

Proteomic and immunologic analyses of brain tumor exosomes

(2008) Michael W. Graner et al.   FASEB JOURNAL

Induction of myeloid-derived suppressor cells by tumor exosomes

(2008) Xiaoyu Xiang et al.   INTERNATIONAL JOURNAL OF CANCER

Increased exosome production from tumour cell cultures using the Integra CELLine Culture System

(2008) J. Paul Mitchell et al.   JOURNAL OF IMMUNOLOGICAL METHODS